Modified Alginate-Based Hydrogel as a Carrier of the CB2 Agonist JWH133 for Bone Engineering
Main Authors: | Wei Zhou, Qianming Li, Ruixiang Ma, Wei Huang, Xianzuo Zhang, Yingsheng Liu, Ze Xu, Linlin Zhang, Meng Li, Chen Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2021-03-01
|
Series: | ACS Omega |
Online Access: | https://doi.org/10.1021/acsomega.0c06057 |
Similar Items
-
CB2 receptor agonist JWH133 activates AMPK to inhibit growth of C6 glioma cells
by: Wang Feng, et al.
Published: (2019-07-01) -
Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist
by: Hebaallah Mamdouh Hashiesh, et al.
Published: (2021-07-01) -
Treatment with CB2 Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice
by: Rodrigo Araujo Fraga-Silva, et al.
Published: (2013-01-01) -
Anti-apoptotic and Immunomodulatory Effect of CB2 Agonist, JWH133, in a Neonatal Rat Model of Hypoxic-Ischemic Encephalopathy
by: Bhavna Gupta, et al.
Published: (2020-02-01) -
Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice.
by: A N A Verty, et al.
Published: (2015-01-01)